Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 22247489)

1.

Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment.

Miserocchi E, Modorati G, Mosconi P, Colucci A, Bandello F.

Ocul Immunol Inflamm. 2010 Aug;18(4):297-304. doi: 10.3109/09273941003637510.

PMID:
20482406
2.

Visual impairment from cataract and health related quality of life: results from a case-control study in the Philippines.

Polack S, Eusebio C, Fletcher A, Foster A, Kuper H.

Ophthalmic Epidemiol. 2010 Jun;17(3):152-9. doi: 10.3109/09286581003731536.

PMID:
20455844
3.

Quality of life amongst American vs. Canadian patients with retinal diseases.

Johnson D, Hollands S, Hollands H, Schweitzer K, Almeida D, Sharma S.

Curr Opin Ophthalmol. 2010 May;21(3):227-32. doi: 10.1097/ICU.0b013e3283386706. Review.

PMID:
20375896
4.

The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.

Multicenter Uveitis Steroid Treatment Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA.

Am J Ophthalmol. 2010 Apr;149(4):550-561.e10. doi: 10.1016/j.ajo.2009.11.019. Epub 2010 Jan 25.

5.

The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population.

Hirneiss C, Schmid-Tannwald C, Kernt M, Kampik A, Neubauer AS.

Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):85-92. doi: 10.1007/s00417-009-1186-3. Epub 2009 Sep 11.

PMID:
19763598
6.

Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.

Suñer IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM.

Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3629-35. doi: 10.1167/iovs.08-3225. Epub 2009 Feb 28.

PMID:
19255158
7.

Co-morbidity and visual acuity are risk factors for health-related quality of life decline: five-month follow-up EQ-5D data of visually impaired older patients.

van Nispen RM, de Boer MR, Hoeijmakers JG, Ringens PJ, van Rens GH.

Health Qual Life Outcomes. 2009 Feb 25;7:18. doi: 10.1186/1477-7525-7-18.

8.

A pre- and post-treatment evaluation of vision-related quality of life in uveitis.

Venkataraman A, Rathinam SR.

Indian J Ophthalmol. 2008 Jul-Aug;56(4):307-12.

9.

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.

Pickard AS, Neary MP, Cella D.

Health Qual Life Outcomes. 2007 Dec 21;5:70. Erratum in: Health Qual Life Outcomes. 2010;8:4.

10.

Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics.

Nyman JA, Barleen NA, Dowd BE, Russell DW, Coons SJ, Sullivan PW.

Med Care. 2007 Jul;45(7):618-28.

PMID:
17571010
11.

Economic impact of visual impairment and blindness in the United States.

Frick KD, Gower EW, Kempen JH, Wolff JL.

Arch Ophthalmol. 2007 Apr;125(4):544-50.

PMID:
17420375
12.

Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.

Murphy CC, Greiner K, Plskova J, Frost NA, Forrester JV, Dick AD.

Br J Ophthalmol. 2007 Feb;91(2):154-6. Epub 2006 Sep 14.

13.

Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores.

Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG.

Med Decis Making. 2006 Jul-Aug;26(4):391-400.

PMID:
16855127
14.

Quality of life and visual function in patients with intermediate uveitis.

Murphy CC, Hughes EH, Frost NA, Dick AD.

Br J Ophthalmol. 2005 Sep;89(9):1161-5.

15.

Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

Walters SJ, Brazier JE.

Qual Life Res. 2005 Aug;14(6):1523-32. Review.

PMID:
16110932
16.

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Shaw JW, Johnson JA, Coons SJ.

Med Care. 2005 Mar;43(3):203-20.

PMID:
15725977
17.

Uveitis: a potentially blinding disease.

Durrani OM, Meads CA, Murray PI.

Ophthalmologica. 2004 Jul-Aug;218(4):223-36. Review.

PMID:
15258410
18.

Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.

Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA; Submacular Surgery Trials Research Group.

Am J Ophthalmol. 2004 Jul;138(1):91-108.

PMID:
15234287
19.
20.

Correlation between visual function and visual ability in patients with uveitis.

Gardiner AM, Armstrong RA, Dunne MC, Murray PI.

Br J Ophthalmol. 2002 Sep;86(9):993-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk